Global CBD Ingredients Growth Opportunities

Global CBD Ingredients Growth Opportunities

Regulatory Challenges and Product Development to Shape the Market’s Future Growth Potential

RELEASE DATE
14-Sep-2022
REGION
Global
Research Code: K81B-01-00-00-00
SKU: FN00063-GL-MT_26874
$4,950.00
In stock
SKU
FN00063-GL-MT_26874
$4,950.00

Pay by invoice

ENQUIRE NOW

Description

The cannabidiol (CBD) industry’s rapid growth reflects the many needs this compound meets. However, regulatory and health issues related to its use remain unaddressed. This research shines a light on the regulatory landscape and applications related to the global CBD industry.

The study’s geographic segmentation reflects the specific realities of North America; Europe, the Middle East, and Africa (EMEA); Asia-Pacific; and Latin America. Further segmentation breaks down CBD as an ingredient in end applications: Food and beverages, personal care and cosmetics, and single servings (capsules, oils, gummies). While several properties and benefits of using CBD are apparent, scientific evidence is lacking to demonstrate them effectively. Prescription CBD-based drugs must receive approval from competent authorities in each jurisdiction. The control and compliance of these medicines require clinical trials, while CBD does not. Therefore, the scope of this research does not consider pharmaceutically derived products.

Market trends include the legalization and regulation of CBD in each region. The future of this industry depends on the development of CBD frameworks and regulatory environments, including the time taken to implement them. In this sense, Frost & Sullivan includes three scenarios that reflect different CBD adoption and market penetration possibilities.

In general, the use of CBD is set to grow significantly from 2022 to 2030. Latin America will advance as a raw hemp provider while Asia-Pacific has the industrial capacity for extraction and separation of the compound.

The study includes analysis and discussion of growth drivers and restraints, challenges and trends, market sizing and forecasts, supply chain, regulatory environment, competitive environment, and regional dynamics. It concludes with a discussion of 5 big growth opportunities.

Table of Contents

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Cannabidiol (CBD) Ingredients Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation by Application

Regional Segmentation

Health Benefits of CBD-based Products

Key Competitors

Growth Metrics

Regulatory Landscape: North America

Regulatory Landscape: EMEA

Regulatory Landscape: APAC

Regulatory Landscape: Latin America

Growth Drivers

Growth Driver Analysis

Growth Driver Analysis (continued)

Growth Restraints

Growth Restraint Analysis

Growth Restraint Analysis (continued)

Challenges and Trends for the Next 5–10 Years

Forecast Assumptions

Forecast Assumptions (continued)

Revenue Growth Scenario Assumptions

Revenue Growth Scenarios

Revenue Growth Scenarios (continued)

Revenue Growth Scenarios (continued)

Market Sizing and Modeling Assumptions

Revenue Forecast

Revenue Forecast Analysis

Revenue Forecast by Region

Revenue Forecast Analysis by Region

Revenue Forecast by End Application

Revenue Forecast Analysis by End Application

Pricing Trends and Forecast Analysis

CBD Market Supply Chain

CBD Market Supply Chain Analysis

CBD Market Supply Chain Analysis (continued)

Growth Opportunities for Supply Chain Participants

Supply Chain Discussion: Impact of COVID-19

Distribution Channels for CBD Products

Competitive Environment

Competitive Benchmarking: B2B Companies

Competitive Benchmarking: B2B Companies (continued)

Key CBD Market Activity (Mergers and Acquisitions, Partnerships, Collaborations, and Product Launches)

Growth Metrics

Revenue Forecast

Revenue Forecast by End Application

Forecast Analysis by End Application

Growth Metrics

Revenue Forecast

Revenue Forecast by End Application

Forecast Analysis by End Application

Growth Metrics

Revenue Forecast

Revenue Forecast by End Application

Forecast Analysis by End Application

Growth Metrics

Revenue Forecast

Revenue Forecast by End Application

Forecast Analysis by End Application

Growth Opportunity 1: Production of Minor Cannabinoids for Specialized Therapeutic Treatments

Growth Opportunity 1: Production of Minor Cannabinoids for Specialized Therapeutic Treatments (continued)

Growth Opportunity 2: Development of Innovative Products by Combining CBD and Other APIs to Address Specific Market Demands

Growth Opportunity 2: Development of Innovative Products by Combining CBD and Other APIs to Address Specific Market Demands (continued)

Growth Opportunity 3: Developing Extraction and Purification Facilities for Improved Vertical Integration and Standardization

Growth Opportunity 3: Developing Extraction and Purification Facilities for Improved Vertical Integration and Standardization (continued)

Growth Opportunity 4: Harmonized Regulatory Environments for Standardizing the Industry and Boosting Consumer Confidence Levels

Growth Opportunity 4: Harmonized Regulatory Environments for Standardizing the Industry and Boosting Consumer Confidence Levels (continued)

Growth Opportunity 5: Emerging Geographies to Offer Higher Growth Opportunities

Growth Opportunity 5: Emerging Geographies to Offer Higher Growth Opportunities (continued)

Growth Opportunity 6: R&D into Specialized Seed Traits to Ensure Higher CBD Content and Productivity

Growth Opportunity 6: R&D into Specialized Seed Traits to Ensure Higher CBD Content and Productivity (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

The cannabidiol (CBD) industry’s rapid growth reflects the many needs this compound meets. However, regulatory and health issues related to its use remain unaddressed. This research shines a light on the regulatory landscape and applications related to the global CBD industry. The study’s geographic segmentation reflects the specific realities of North America; Europe, the Middle East, and Africa (EMEA); Asia-Pacific; and Latin America. Further segmentation breaks down CBD as an ingredient in end applications: Food and beverages, personal care and cosmetics, and single servings (capsules, oils, gummies). While several properties and benefits of using CBD are apparent, scientific evidence is lacking to demonstrate them effectively. Prescription CBD-based drugs must receive approval from competent authorities in each jurisdiction. The control and compliance of these medicines require clinical trials, while CBD does not. Therefore, the scope of this research does not consider pharmaceutically derived products. Market trends include the legalization and regulation of CBD in each region. The future of this industry depends on the development of CBD frameworks and regulatory environments, including the time taken to implement them. In this sense, Frost & Sullivan includes three scenarios that reflect different CBD adoption and market penetration possibilities. In general, the use of CBD is set to grow significantly from 2022 to 2030. Latin America will advance as a raw hemp provider while Asia-Pacific has the industrial capacity for extraction and separation of the compound. The study includes analysis and discussion of growth drivers and restraints, challenges and trends, market sizing and forecasts, supply chain, regulatory environment, competitive environment, and regional dynamics. It concludes with a discussion of 5 big growth opportunities.
More Information
Author Matias Guarnera
Industries Agriculture and Nutrition
No Index No
Is Prebook No
Podcast No
WIP Number K81B-01-00-00-00